Envarsus XR 4 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FEHZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,543
Award facts
- Contract value 100% obligated
- $20,543.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $20,543.40. This is a non-set-aside award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025.
This delivery order supports military healthcare supply chain operations through AmerisourceBergen's established pharmaceutical distribution capabilities. As a major pharmaceutical distributor, AmerisourceBergen serves federal medical procurement needs by supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The SPE2DX contract vehicle functions as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure with a defined ceiling reflects standard procurement practices for pharmaceutical delivery orders issued under DLA's medical supply chain programs.
Quick answers
Who was awarded contract SPE2DB25FEHZT?
SPE2DB25FEHZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FEHZT worth?
The government has obligated $20,543 on SPE2DB25FEHZT.
Is contract SPE2DB25FEHZT an order under another contract?
Yes. SPE2DB25FEHZT is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHZT competed?
The extent of competition for SPE2DB25FEHZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award